BIO - Bio-Rad Laboratories, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts4444
Avg. Estimate1.151.527.099.16
Low estimate0.991.366.748.56
High estimate1.451.687.379.58
Year ago EPS1.491.617.067.09
Revenue estimateCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
No. of analysts3333
Avg. Estimate503.82M553.12M2.27B2.44B
Low estimate487.1M543.47M2.26B2.4B
High estimate525.15M558.1M2.27B2.47B
Year ago sales572.62M560.63M2.31B2.27B
Sales growth (year/est)-12.00%-1.30%-1.90%7.40%
Earnings history29/06/201929/09/201930/12/201930/03/2020
Est. EPS1.331.42.441.56
Actual EPS1.491.612.321.91
Difference0.160.21-0.120.35
Surprise %12.00%15.00%-4.90%22.40%
EPS trendCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Current estimate1.151.527.099.16
7 days ago1.151.527.099.16
30 days ago1.051.637.169.07
60 days ago1.451.817.489.16
90 days ago1.771.867.859.37
EPS revisionsCurrent qtr. (Jun 2020)Next qtr. (Sep 2020)Current year (2020)Next year (2021)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesBIOIndustrySector(s)S&P 500
Current qtr.-22.80%N/AN/AN/A
Next qtr.-5.60%N/AN/AN/A
Current year0.40%N/AN/AN/A
Next year29.20%N/AN/AN/A
Next 5 years (per annum)17.80%N/AN/AN/A
Past 5 years (per annum)12.03%N/AN/AN/A